Phenelzine Sulfate

硫酸苯乙肼

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePhenelzine Sulfate
Drug Alias Namephenelzinum苯乙肼硫酸盐fenelzinaNardil
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase inhibitors
TargetsMonoamine oxidase
Therapy Area/IndicationsDepressive Disorder, MajorProstatic Neoplasms
Global Approved IndicationsDepressive Disorder, Major
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1961/06/09
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesParke Davis Pharmaceutical Research Div Warner Lambert Co
Inactive CompaniesUniversity Of Southern CaliforniaCelgene Corp
Active IndicationsDepressive Disorder, Major
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN06AF03
Related LinksWikipediaDrugBankKEGG